Hans Frykman Hello and good year to all.
Decided to get the ball rolling in 2022 with an observation I made recently looking at Promis's revamped web site and noticed that Hans Frykman is no longer on their scientific advisory board.
I will admit that I'm a little disappointed even though there seemed little hope in anything coming out of the Immusafe effort, his absence on the SAB seems to put the nail in the coffin. I always hoped that Promis would piggyback off the COViD experience to legitimize their science in the ALS and Alzheimer field to least propel their share price to the 0.40-0.50 range before consolidation.....
who knows, this might still be in the works, but you have to wonder why Hans is no longer there.
Any thoughts?